nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Headache—Lenalidomide—hematologic cancer	0.000725	0.00086	CcSEcCtD
Propantheline—Rash—Hydroxyurea—hematologic cancer	0.000719	0.000853	CcSEcCtD
Propantheline—Confusional state—Etoposide—hematologic cancer	0.000719	0.000853	CcSEcCtD
Propantheline—Dermatitis—Hydroxyurea—hematologic cancer	0.000718	0.000852	CcSEcCtD
Propantheline—Urticaria—Ifosfamide—hematologic cancer	0.000717	0.000851	CcSEcCtD
Propantheline—Headache—Hydroxyurea—hematologic cancer	0.000714	0.000848	CcSEcCtD
Propantheline—Constipation—Gemcitabine—hematologic cancer	0.000714	0.000847	CcSEcCtD
Propantheline—Anaphylactic shock—Etoposide—hematologic cancer	0.000713	0.000846	CcSEcCtD
Propantheline—Asthenia—Thiotepa—hematologic cancer	0.000712	0.000845	CcSEcCtD
Propantheline—Abdominal distension—Epirubicin—hematologic cancer	0.000707	0.000839	CcSEcCtD
Propantheline—Hypersensitivity—Thalidomide—hematologic cancer	0.000707	0.000839	CcSEcCtD
Propantheline—Nausea—Melphalan—hematologic cancer	0.000707	0.000838	CcSEcCtD
Propantheline—Feeling abnormal—Irinotecan—hematologic cancer	0.000706	0.000838	CcSEcCtD
Propantheline—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000706	0.000838	CcSEcCtD
Propantheline—Dizziness—Bortezomib—hematologic cancer	0.000704	0.000835	CcSEcCtD
Propantheline—Anaphylactic shock—Prednisolone—hematologic cancer	0.000703	0.000834	CcSEcCtD
Propantheline—Dysphagia—Epirubicin—hematologic cancer	0.000703	0.000834	CcSEcCtD
Propantheline—Tachycardia—Etoposide—hematologic cancer	0.000696	0.000826	CcSEcCtD
Propantheline—Erectile dysfunction—Methotrexate—hematologic cancer	0.000692	0.000821	CcSEcCtD
Propantheline—Asthenia—Thalidomide—hematologic cancer	0.000689	0.000817	CcSEcCtD
Propantheline—Feeling abnormal—Gemcitabine—hematologic cancer	0.000688	0.000816	CcSEcCtD
Propantheline—Dizziness—Vinorelbine—hematologic cancer	0.000687	0.000815	CcSEcCtD
Propantheline—Nausea—Lenalidomide—hematologic cancer	0.000687	0.000815	CcSEcCtD
Propantheline—Tachycardia—Prednisolone—hematologic cancer	0.000686	0.000814	CcSEcCtD
Propantheline—Urticaria—Mitoxantrone—hematologic cancer	0.000681	0.000808	CcSEcCtD
Propantheline—Hypersensitivity—Carmustine—hematologic cancer	0.000679	0.000806	CcSEcCtD
Propantheline—Nausea—Hydroxyurea—hematologic cancer	0.000677	0.000804	CcSEcCtD
Propantheline—Vomiting—Bortezomib—hematologic cancer	0.000677	0.000803	CcSEcCtD
Propantheline—Hypersensitivity—Alitretinoin—hematologic cancer	0.000673	0.000798	CcSEcCtD
Propantheline—Vomiting—Bleomycin—hematologic cancer	0.000672	0.000797	CcSEcCtD
Propantheline—Rash—Bortezomib—hematologic cancer	0.000671	0.000796	CcSEcCtD
Propantheline—Dermatitis—Bortezomib—hematologic cancer	0.00067	0.000796	CcSEcCtD
Propantheline—Drowsiness—Methotrexate—hematologic cancer	0.00067	0.000795	CcSEcCtD
Propantheline—Flushing—Prednisone—hematologic cancer	0.000667	0.000792	CcSEcCtD
Propantheline—Headache—Bortezomib—hematologic cancer	0.000667	0.000791	CcSEcCtD
Propantheline—Rash—Bleomycin—hematologic cancer	0.000666	0.00079	CcSEcCtD
Propantheline—Dermatitis—Bleomycin—hematologic cancer	0.000665	0.000789	CcSEcCtD
Propantheline—Hypersensitivity—Ifosfamide—hematologic cancer	0.000665	0.000789	CcSEcCtD
Propantheline—Asthenia—Carmustine—hematologic cancer	0.000661	0.000785	CcSEcCtD
Propantheline—Vomiting—Vinorelbine—hematologic cancer	0.000661	0.000784	CcSEcCtD
Propantheline—Dry mouth—Triamcinolone—hematologic cancer	0.00066	0.000783	CcSEcCtD
Propantheline—Dizziness—Thiotepa—hematologic cancer	0.000656	0.000779	CcSEcCtD
Propantheline—Asthenia—Alitretinoin—hematologic cancer	0.000655	0.000778	CcSEcCtD
Propantheline—Rash—Vinorelbine—hematologic cancer	0.000655	0.000778	CcSEcCtD
Propantheline—Dermatitis—Vinorelbine—hematologic cancer	0.000655	0.000777	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—hematologic cancer	0.000655	0.000777	CcSEcCtD
Propantheline—Headache—Vinorelbine—hematologic cancer	0.000651	0.000773	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—hematologic cancer	0.00065	0.000772	CcSEcCtD
Propantheline—Hypersensitivity—Vincristine—hematologic cancer	0.000648	0.000769	CcSEcCtD
Propantheline—Asthenia—Ifosfamide—hematologic cancer	0.000648	0.000769	CcSEcCtD
Propantheline—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000647	0.000767	CcSEcCtD
Propantheline—Feeling abnormal—Cisplatin—hematologic cancer	0.000641	0.000761	CcSEcCtD
Propantheline—Insomnia—Prednisolone—hematologic cancer	0.000636	0.000755	CcSEcCtD
Propantheline—Dizziness—Thalidomide—hematologic cancer	0.000635	0.000753	CcSEcCtD
Propantheline—Somnolence—Etoposide—hematologic cancer	0.000634	0.000752	CcSEcCtD
Propantheline—Nausea—Bortezomib—hematologic cancer	0.000632	0.00075	CcSEcCtD
Propantheline—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000631	0.000749	CcSEcCtD
Propantheline—Hypersensitivity—Irinotecan—hematologic cancer	0.000631	0.000749	CcSEcCtD
Propantheline—Asthenia—Vincristine—hematologic cancer	0.000631	0.000749	CcSEcCtD
Propantheline—Tachycardia—Triamcinolone—hematologic cancer	0.000631	0.000749	CcSEcCtD
Propantheline—Vomiting—Thiotepa—hematologic cancer	0.000631	0.000749	CcSEcCtD
Propantheline—Nausea—Bleomycin—hematologic cancer	0.000627	0.000744	CcSEcCtD
Propantheline—Drowsiness—Epirubicin—hematologic cancer	0.000627	0.000744	CcSEcCtD
Propantheline—Rash—Thiotepa—hematologic cancer	0.000626	0.000743	CcSEcCtD
Propantheline—Dermatitis—Thiotepa—hematologic cancer	0.000625	0.000742	CcSEcCtD
Propantheline—Headache—Thiotepa—hematologic cancer	0.000622	0.000738	CcSEcCtD
Propantheline—Nausea—Vinorelbine—hematologic cancer	0.000617	0.000732	CcSEcCtD
Propantheline—Asthenia—Mitoxantrone—hematologic cancer	0.000615	0.00073	CcSEcCtD
Propantheline—Asthenia—Irinotecan—hematologic cancer	0.000615	0.00073	CcSEcCtD
Propantheline—Vomiting—Thalidomide—hematologic cancer	0.00061	0.000724	CcSEcCtD
Propantheline—Dizziness—Carmustine—hematologic cancer	0.00061	0.000723	CcSEcCtD
Propantheline—Constipation—Etoposide—hematologic cancer	0.00061	0.000723	CcSEcCtD
Propantheline—Rash—Thalidomide—hematologic cancer	0.000605	0.000718	CcSEcCtD
Propantheline—Dermatitis—Thalidomide—hematologic cancer	0.000605	0.000718	CcSEcCtD
Propantheline—Dizziness—Alitretinoin—hematologic cancer	0.000604	0.000717	CcSEcCtD
Propantheline—Headache—Thalidomide—hematologic cancer	0.000601	0.000714	CcSEcCtD
Propantheline—Asthenia—Gemcitabine—hematologic cancer	0.000599	0.000711	CcSEcCtD
Propantheline—Dizziness—Ifosfamide—hematologic cancer	0.000597	0.000708	CcSEcCtD
Propantheline—Vision blurred—Prednisone—hematologic cancer	0.00059	0.0007	CcSEcCtD
Propantheline—Nausea—Thiotepa—hematologic cancer	0.00059	0.0007	CcSEcCtD
Propantheline—Feeling abnormal—Etoposide—hematologic cancer	0.000587	0.000697	CcSEcCtD
Propantheline—Anaphylactic shock—Betamethasone—hematologic cancer	0.000587	0.000696	CcSEcCtD
Propantheline—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000587	0.000696	CcSEcCtD
Propantheline—Vomiting—Carmustine—hematologic cancer	0.000586	0.000696	CcSEcCtD
Propantheline—Insomnia—Triamcinolone—hematologic cancer	0.000585	0.000694	CcSEcCtD
Propantheline—Dizziness—Vincristine—hematologic cancer	0.000582	0.000691	CcSEcCtD
Propantheline—Rash—Carmustine—hematologic cancer	0.000581	0.00069	CcSEcCtD
Propantheline—Dermatitis—Carmustine—hematologic cancer	0.000581	0.000689	CcSEcCtD
Propantheline—Vomiting—Alitretinoin—hematologic cancer	0.000581	0.000689	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—hematologic cancer	0.00058	0.000688	CcSEcCtD
Propantheline—Feeling abnormal—Prednisolone—hematologic cancer	0.000579	0.000688	CcSEcCtD
Propantheline—Headache—Carmustine—hematologic cancer	0.000578	0.000685	CcSEcCtD
Propantheline—Rash—Alitretinoin—hematologic cancer	0.000576	0.000683	CcSEcCtD
Propantheline—Dermatitis—Alitretinoin—hematologic cancer	0.000575	0.000683	CcSEcCtD
Propantheline—Vomiting—Ifosfamide—hematologic cancer	0.000574	0.000681	CcSEcCtD
Propantheline—Hypersensitivity—Cisplatin—hematologic cancer	0.000573	0.00068	CcSEcCtD
Propantheline—Tachycardia—Dexamethasone—hematologic cancer	0.000573	0.00068	CcSEcCtD
Propantheline—Tachycardia—Betamethasone—hematologic cancer	0.000573	0.00068	CcSEcCtD
Propantheline—Headache—Alitretinoin—hematologic cancer	0.000572	0.000679	CcSEcCtD
Propantheline—Nausea—Thalidomide—hematologic cancer	0.00057	0.000677	CcSEcCtD
Propantheline—Rash—Ifosfamide—hematologic cancer	0.000569	0.000675	CcSEcCtD
Propantheline—Dermatitis—Ifosfamide—hematologic cancer	0.000569	0.000675	CcSEcCtD
Propantheline—Dizziness—Irinotecan—hematologic cancer	0.000567	0.000673	CcSEcCtD
Propantheline—Urticaria—Etoposide—hematologic cancer	0.000566	0.000672	CcSEcCtD
Propantheline—Vomiting—Vincristine—hematologic cancer	0.00056	0.000664	CcSEcCtD
Propantheline—Urticaria—Prednisolone—hematologic cancer	0.000559	0.000663	CcSEcCtD
Propantheline—Asthenia—Cisplatin—hematologic cancer	0.000558	0.000663	CcSEcCtD
Propantheline—Rash—Vincristine—hematologic cancer	0.000555	0.000658	CcSEcCtD
Propantheline—Dermatitis—Vincristine—hematologic cancer	0.000554	0.000658	CcSEcCtD
Propantheline—Headache—Vincristine—hematologic cancer	0.000551	0.000654	CcSEcCtD
Propantheline—Nausea—Carmustine—hematologic cancer	0.000548	0.00065	CcSEcCtD
Propantheline—Vomiting—Irinotecan—hematologic cancer	0.000545	0.000647	CcSEcCtD
Propantheline—Vomiting—Mitoxantrone—hematologic cancer	0.000545	0.000647	CcSEcCtD
Propantheline—Nausea—Alitretinoin—hematologic cancer	0.000542	0.000644	CcSEcCtD
Propantheline—Rash—Mitoxantrone—hematologic cancer	0.00054	0.000641	CcSEcCtD
Propantheline—Rash—Irinotecan—hematologic cancer	0.00054	0.000641	CcSEcCtD
Propantheline—Dermatitis—Mitoxantrone—hematologic cancer	0.00054	0.000641	CcSEcCtD
Propantheline—Dermatitis—Irinotecan—hematologic cancer	0.00054	0.000641	CcSEcCtD
Propantheline—Headache—Irinotecan—hematologic cancer	0.000537	0.000637	CcSEcCtD
Propantheline—Headache—Mitoxantrone—hematologic cancer	0.000537	0.000637	CcSEcCtD
Propantheline—Nausea—Ifosfamide—hematologic cancer	0.000536	0.000636	CcSEcCtD
Propantheline—Feeling abnormal—Triamcinolone—hematologic cancer	0.000533	0.000632	CcSEcCtD
Propantheline—Vomiting—Gemcitabine—hematologic cancer	0.000531	0.00063	CcSEcCtD
Propantheline—Insomnia—Betamethasone—hematologic cancer	0.000531	0.00063	CcSEcCtD
Propantheline—Insomnia—Dexamethasone—hematologic cancer	0.000531	0.00063	CcSEcCtD
Propantheline—Rash—Gemcitabine—hematologic cancer	0.000526	0.000625	CcSEcCtD
Propantheline—Dermatitis—Gemcitabine—hematologic cancer	0.000526	0.000624	CcSEcCtD
Propantheline—Hypersensitivity—Etoposide—hematologic cancer	0.000525	0.000623	CcSEcCtD
Propantheline—Headache—Gemcitabine—hematologic cancer	0.000523	0.000621	CcSEcCtD
Propantheline—Nausea—Vincristine—hematologic cancer	0.000523	0.00062	CcSEcCtD
Propantheline—Flushing—Epirubicin—hematologic cancer	0.000522	0.000619	CcSEcCtD
Propantheline—Hypersensitivity—Prednisolone—hematologic cancer	0.000518	0.000615	CcSEcCtD
Propantheline—Urticaria—Triamcinolone—hematologic cancer	0.000514	0.00061	CcSEcCtD
Propantheline—Asthenia—Etoposide—hematologic cancer	0.000511	0.000607	CcSEcCtD
Propantheline—Anaphylactic shock—Prednisone—hematologic cancer	0.000511	0.000606	CcSEcCtD
Propantheline—Nausea—Mitoxantrone—hematologic cancer	0.000509	0.000604	CcSEcCtD
Propantheline—Nausea—Irinotecan—hematologic cancer	0.000509	0.000604	CcSEcCtD
Propantheline—Tachycardia—Prednisone—hematologic cancer	0.000499	0.000592	CcSEcCtD
Propantheline—Nausea—Gemcitabine—hematologic cancer	0.000496	0.000588	CcSEcCtD
Propantheline—Vomiting—Cisplatin—hematologic cancer	0.000495	0.000587	CcSEcCtD
Propantheline—Vision blurred—Methotrexate—hematologic cancer	0.000493	0.000585	CcSEcCtD
Propantheline—Rash—Cisplatin—hematologic cancer	0.000491	0.000582	CcSEcCtD
Propantheline—Dermatitis—Cisplatin—hematologic cancer	0.00049	0.000582	CcSEcCtD
Propantheline—Feeling abnormal—Dexamethasone—hematologic cancer	0.000483	0.000574	CcSEcCtD
Propantheline—Feeling abnormal—Betamethasone—hematologic cancer	0.000483	0.000574	CcSEcCtD
Propantheline—Flushing—Doxorubicin—hematologic cancer	0.000483	0.000573	CcSEcCtD
Propantheline—Tension—Epirubicin—hematologic cancer	0.00048	0.00057	CcSEcCtD
Propantheline—Hypersensitivity—Triamcinolone—hematologic cancer	0.000476	0.000565	CcSEcCtD
Propantheline—Nervousness—Epirubicin—hematologic cancer	0.000476	0.000564	CcSEcCtD
Propantheline—Dizziness—Etoposide—hematologic cancer	0.000471	0.000559	CcSEcCtD
Propantheline—Urticaria—Dexamethasone—hematologic cancer	0.000466	0.000553	CcSEcCtD
Propantheline—Urticaria—Betamethasone—hematologic cancer	0.000466	0.000553	CcSEcCtD
Propantheline—Dizziness—Prednisolone—hematologic cancer	0.000465	0.000552	CcSEcCtD
Propantheline—Asthenia—Triamcinolone—hematologic cancer	0.000464	0.000551	CcSEcCtD
Propantheline—Nausea—Cisplatin—hematologic cancer	0.000462	0.000549	CcSEcCtD
Propantheline—Insomnia—Prednisone—hematologic cancer	0.000462	0.000548	CcSEcCtD
Propantheline—Vision blurred—Epirubicin—hematologic cancer	0.000461	0.000548	CcSEcCtD
Propantheline—Vomiting—Etoposide—hematologic cancer	0.000453	0.000538	CcSEcCtD
Propantheline—Rash—Etoposide—hematologic cancer	0.00045	0.000533	CcSEcCtD
Propantheline—Dermatitis—Etoposide—hematologic cancer	0.000449	0.000533	CcSEcCtD
Propantheline—Headache—Etoposide—hematologic cancer	0.000447	0.00053	CcSEcCtD
Propantheline—Tension—Doxorubicin—hematologic cancer	0.000445	0.000528	CcSEcCtD
Propantheline—Rash—Prednisolone—hematologic cancer	0.000443	0.000526	CcSEcCtD
Propantheline—Dermatitis—Prednisolone—hematologic cancer	0.000443	0.000526	CcSEcCtD
Propantheline—Headache—Prednisolone—hematologic cancer	0.000441	0.000523	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—hematologic cancer	0.00044	0.000522	CcSEcCtD
Propantheline—Constipation—Prednisone—hematologic cancer	0.000437	0.000518	CcSEcCtD
Propantheline—Palpitations—Epirubicin—hematologic cancer	0.000433	0.000513	CcSEcCtD
Propantheline—Confusional state—Methotrexate—hematologic cancer	0.000431	0.000511	CcSEcCtD
Propantheline—Dizziness—Triamcinolone—hematologic cancer	0.000428	0.000507	CcSEcCtD
Propantheline—Anaphylactic shock—Methotrexate—hematologic cancer	0.000427	0.000507	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—hematologic cancer	0.000427	0.000507	CcSEcCtD
Propantheline—Nausea—Etoposide—hematologic cancer	0.000423	0.000502	CcSEcCtD
Propantheline—Feeling abnormal—Prednisone—hematologic cancer	0.000421	0.0005	CcSEcCtD
Propantheline—Asthenia—Dexamethasone—hematologic cancer	0.000421	0.0005	CcSEcCtD
Propantheline—Asthenia—Betamethasone—hematologic cancer	0.000421	0.0005	CcSEcCtD
Propantheline—Nausea—Prednisolone—hematologic cancer	0.000418	0.000496	CcSEcCtD
Propantheline—Vomiting—Triamcinolone—hematologic cancer	0.000411	0.000488	CcSEcCtD
Propantheline—Rash—Triamcinolone—hematologic cancer	0.000408	0.000484	CcSEcCtD
Propantheline—Dry mouth—Epirubicin—hematologic cancer	0.000408	0.000484	CcSEcCtD
Propantheline—Dermatitis—Triamcinolone—hematologic cancer	0.000407	0.000483	CcSEcCtD
Propantheline—Urticaria—Prednisone—hematologic cancer	0.000406	0.000482	CcSEcCtD
Propantheline—Headache—Triamcinolone—hematologic cancer	0.000405	0.000481	CcSEcCtD
Propantheline—Confusional state—Epirubicin—hematologic cancer	0.000403	0.000478	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—hematologic cancer	0.0004	0.000475	CcSEcCtD
Propantheline—Anaphylactic shock—Epirubicin—hematologic cancer	0.0004	0.000474	CcSEcCtD
Propantheline—Tachycardia—Epirubicin—hematologic cancer	0.00039	0.000463	CcSEcCtD
Propantheline—Dizziness—Dexamethasone—hematologic cancer	0.000388	0.00046	CcSEcCtD
Propantheline—Dizziness—Betamethasone—hematologic cancer	0.000388	0.00046	CcSEcCtD
Propantheline—Insomnia—Methotrexate—hematologic cancer	0.000386	0.000458	CcSEcCtD
Propantheline—Nausea—Triamcinolone—hematologic cancer	0.000384	0.000456	CcSEcCtD
Propantheline—Somnolence—Methotrexate—hematologic cancer	0.00038	0.00045	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—hematologic cancer	0.000377	0.000448	CcSEcCtD
Propantheline—Hypersensitivity—Prednisone—hematologic cancer	0.000376	0.000447	CcSEcCtD
Propantheline—Vomiting—Betamethasone—hematologic cancer	0.000373	0.000443	CcSEcCtD
Propantheline—Vomiting—Dexamethasone—hematologic cancer	0.000373	0.000443	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—hematologic cancer	0.000373	0.000442	CcSEcCtD
Propantheline—Rash—Dexamethasone—hematologic cancer	0.00037	0.000439	CcSEcCtD
Propantheline—Rash—Betamethasone—hematologic cancer	0.00037	0.000439	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—hematologic cancer	0.00037	0.000439	CcSEcCtD
Propantheline—Dermatitis—Betamethasone—hematologic cancer	0.00037	0.000439	CcSEcCtD
Propantheline—Dermatitis—Dexamethasone—hematologic cancer	0.00037	0.000439	CcSEcCtD
Propantheline—Headache—Dexamethasone—hematologic cancer	0.000368	0.000436	CcSEcCtD
Propantheline—Headache—Betamethasone—hematologic cancer	0.000368	0.000436	CcSEcCtD
Propantheline—Asthenia—Prednisone—hematologic cancer	0.000367	0.000435	CcSEcCtD
Propantheline—Insomnia—Epirubicin—hematologic cancer	0.000361	0.000429	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—hematologic cancer	0.000361	0.000428	CcSEcCtD
Propantheline—Somnolence—Epirubicin—hematologic cancer	0.000355	0.000422	CcSEcCtD
Propantheline—Feeling abnormal—Methotrexate—hematologic cancer	0.000352	0.000418	CcSEcCtD
Propantheline—Nausea—Dexamethasone—hematologic cancer	0.000349	0.000414	CcSEcCtD
Propantheline—Nausea—Betamethasone—hematologic cancer	0.000349	0.000414	CcSEcCtD
Propantheline—Constipation—Epirubicin—hematologic cancer	0.000342	0.000406	CcSEcCtD
Propantheline—Urticaria—Methotrexate—hematologic cancer	0.000339	0.000403	CcSEcCtD
Propantheline—Dizziness—Prednisone—hematologic cancer	0.000338	0.000401	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—hematologic cancer	0.000334	0.000397	CcSEcCtD
Propantheline—Feeling abnormal—Epirubicin—hematologic cancer	0.000329	0.000391	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—hematologic cancer	0.000329	0.00039	CcSEcCtD
Propantheline—Vomiting—Prednisone—hematologic cancer	0.000325	0.000386	CcSEcCtD
Propantheline—Rash—Prednisone—hematologic cancer	0.000322	0.000382	CcSEcCtD
Propantheline—Dermatitis—Prednisone—hematologic cancer	0.000322	0.000382	CcSEcCtD
Propantheline—Headache—Prednisone—hematologic cancer	0.00032	0.00038	CcSEcCtD
Propantheline—Urticaria—Epirubicin—hematologic cancer	0.000317	0.000377	CcSEcCtD
Propantheline—Constipation—Doxorubicin—hematologic cancer	0.000316	0.000375	CcSEcCtD
Propantheline—Hypersensitivity—Methotrexate—hematologic cancer	0.000315	0.000373	CcSEcCtD
Propantheline—Asthenia—Methotrexate—hematologic cancer	0.000306	0.000364	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—hematologic cancer	0.000305	0.000362	CcSEcCtD
Propantheline—Nausea—Prednisone—hematologic cancer	0.000304	0.00036	CcSEcCtD
Propantheline—Hypersensitivity—Epirubicin—hematologic cancer	0.000294	0.000349	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—hematologic cancer	0.000294	0.000349	CcSEcCtD
Propantheline—Asthenia—Epirubicin—hematologic cancer	0.000287	0.00034	CcSEcCtD
Propantheline—Dizziness—Methotrexate—hematologic cancer	0.000282	0.000335	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—hematologic cancer	0.000272	0.000323	CcSEcCtD
Propantheline—Vomiting—Methotrexate—hematologic cancer	0.000272	0.000322	CcSEcCtD
Propantheline—Rash—Methotrexate—hematologic cancer	0.000269	0.000319	CcSEcCtD
Propantheline—Dermatitis—Methotrexate—hematologic cancer	0.000269	0.000319	CcSEcCtD
Propantheline—Headache—Methotrexate—hematologic cancer	0.000268	0.000317	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—hematologic cancer	0.000265	0.000315	CcSEcCtD
Propantheline—Dizziness—Epirubicin—hematologic cancer	0.000264	0.000314	CcSEcCtD
Propantheline—Vomiting—Epirubicin—hematologic cancer	0.000254	0.000302	CcSEcCtD
Propantheline—Nausea—Methotrexate—hematologic cancer	0.000254	0.000301	CcSEcCtD
Propantheline—Rash—Epirubicin—hematologic cancer	0.000252	0.000299	CcSEcCtD
Propantheline—Dermatitis—Epirubicin—hematologic cancer	0.000252	0.000299	CcSEcCtD
Propantheline—Headache—Epirubicin—hematologic cancer	0.00025	0.000297	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—hematologic cancer	0.000245	0.00029	CcSEcCtD
Propantheline—Nausea—Epirubicin—hematologic cancer	0.000237	0.000282	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—hematologic cancer	0.000235	0.000279	CcSEcCtD
Propantheline—Rash—Doxorubicin—hematologic cancer	0.000233	0.000277	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—hematologic cancer	0.000233	0.000276	CcSEcCtD
Propantheline—Headache—Doxorubicin—hematologic cancer	0.000232	0.000275	CcSEcCtD
Propantheline—Nausea—Doxorubicin—hematologic cancer	0.00022	0.000261	CcSEcCtD
Propantheline—CHRM3—Signaling Pathways—PDGFA—hematologic cancer	3.82e-05	0.000243	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	3.82e-05	0.000243	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GRB2—hematologic cancer	3.8e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	3.79e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	3.79e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KITLG—hematologic cancer	3.78e-05	0.00024	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KITLG—hematologic cancer	3.77e-05	0.00024	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KITLG—hematologic cancer	3.73e-05	0.000237	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT5A—hematologic cancer	3.7e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.69e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT5A—hematologic cancer	3.68e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CB—hematologic cancer	3.67e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN2B—hematologic cancer	3.66e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—hematologic cancer	3.66e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN2B—hematologic cancer	3.65e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	3.65e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	3.64e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3R1—hematologic cancer	3.63e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	3.62e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3R1—hematologic cancer	3.61e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	3.58e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CD86—hematologic cancer	3.54e-05	0.000225	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CD86—hematologic cancer	3.53e-05	0.000225	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—JAK2—hematologic cancer	3.52e-05	0.000224	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—JAK2—hematologic cancer	3.51e-05	0.000223	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CD86—hematologic cancer	3.5e-05	0.000222	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HES1—hematologic cancer	3.49e-05	0.000222	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HES1—hematologic cancer	3.48e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	3.48e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NCOR1—hematologic cancer	3.47e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NCOR1—hematologic cancer	3.46e-05	0.00022	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HES1—hematologic cancer	3.45e-05	0.000219	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CSF2—hematologic cancer	3.44e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF1—hematologic cancer	3.44e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	3.43e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CSF2—hematologic cancer	3.42e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF1—hematologic cancer	3.42e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CSF2—hematologic cancer	3.39e-05	0.000216	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF1—hematologic cancer	3.39e-05	0.000216	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	3.39e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	3.38e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	3.38e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	3.38e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	3.37e-05	0.000214	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	3.37e-05	0.000214	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	3.35e-05	0.000213	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	3.34e-05	0.000213	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	3.34e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	3.34e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	3.34e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	3.33e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	3.32e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JAK1—hematologic cancer	3.32e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	3.32e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JAK1—hematologic cancer	3.31e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	3.31e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	3.3e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	3.28e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	3.27e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JAK1—hematologic cancer	3.27e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	3.1e-05	0.000197	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	3.09e-05	0.000196	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—hematologic cancer	3.08e-05	0.000196	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL2—hematologic cancer	3.07e-05	0.000195	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL2—hematologic cancer	3.06e-05	0.000195	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TERT—hematologic cancer	3.06e-05	0.000195	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	3.06e-05	0.000194	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TERT—hematologic cancer	3.05e-05	0.000194	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL2—hematologic cancer	3.03e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TERT—hematologic cancer	3.02e-05	0.000192	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	2.99e-05	0.00019	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	2.98e-05	0.000189	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	2.95e-05	0.000188	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TSC2—hematologic cancer	2.92e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TSC2—hematologic cancer	2.91e-05	0.000185	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TSC2—hematologic cancer	2.88e-05	0.000183	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CREBBP—hematologic cancer	2.85e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	2.81e-05	0.000179	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	2.8e-05	0.000178	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	2.78e-05	0.000177	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	2.77e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	2.77e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	2.75e-05	0.000175	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ESR1—hematologic cancer	2.73e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ESR1—hematologic cancer	2.72e-05	0.000173	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CD—hematologic cancer	2.7e-05	0.000172	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FN1—hematologic cancer	2.7e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ESR1—hematologic cancer	2.69e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FN1—hematologic cancer	2.69e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—hematologic cancer	2.67e-05	0.00017	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	2.66e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BAD—hematologic cancer	2.66e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FN1—hematologic cancer	2.66e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	2.66e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BAD—hematologic cancer	2.66e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	2.64e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	2.63e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BAD—hematologic cancer	2.63e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	2.63e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	2.6e-05	0.000166	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CD80—hematologic cancer	2.58e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	2.58e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KIT—hematologic cancer	2.58e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	2.58e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CD80—hematologic cancer	2.58e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KIT—hematologic cancer	2.57e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	2.57e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	2.57e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3R1—hematologic cancer	2.55e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CD80—hematologic cancer	2.55e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	2.55e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KIT—hematologic cancer	2.55e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	2.55e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	2.53e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	2.53e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	2.5e-05	0.000159	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.47e-05	0.000157	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	2.46e-05	0.000157	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CREB1—hematologic cancer	2.46e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CREB1—hematologic cancer	2.45e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	2.44e-05	0.000155	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BRAF—hematologic cancer	2.43e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CREB1—hematologic cancer	2.42e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BRAF—hematologic cancer	2.42e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL2—hematologic cancer	2.4e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6R—hematologic cancer	2.4e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL2—hematologic cancer	2.4e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BRAF—hematologic cancer	2.39e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	2.39e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6R—hematologic cancer	2.39e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	2.38e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL2—hematologic cancer	2.37e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6R—hematologic cancer	2.36e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	2.36e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CB—hematologic cancer	2.36e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.28e-05	0.000145	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	2.28e-05	0.000145	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.27e-05	0.000144	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	2.26e-05	0.000144	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	2.25e-05	0.000143	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.25e-05	0.000143	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	2.24e-05	0.000142	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	2.24e-05	0.000142	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	2.22e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.22e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	2.21e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	2.19e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF2—hematologic cancer	2.17e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF2—hematologic cancer	2.16e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF2—hematologic cancer	2.14e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.14e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	2.13e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	2.11e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JAK2—hematologic cancer	2.08e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JAK2—hematologic cancer	2.07e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JAK2—hematologic cancer	2.05e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.04e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTEN—hematologic cancer	2.04e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	2.03e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MDM2—hematologic cancer	2.03e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MDM2—hematologic cancer	2.03e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	2.01e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MDM2—hematologic cancer	2.01e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MTOR—hematologic cancer	1.98e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.98e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	1.97e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MTOR—hematologic cancer	1.97e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.95e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.95e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—EP300—hematologic cancer	1.94e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	1.89e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	1.88e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.86e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	1.86e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	1.85e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	1.84e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.83e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	1.83e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—hematologic cancer	1.82e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL2—hematologic cancer	1.82e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—hematologic cancer	1.81e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.81e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL2—hematologic cancer	1.81e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—hematologic cancer	1.81e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—hematologic cancer	1.8e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.79e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.79e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.78e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCND1—hematologic cancer	1.77e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JUN—hematologic cancer	1.77e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCND1—hematologic cancer	1.76e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JUN—hematologic cancer	1.76e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.75e-05	0.000111	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.74e-05	0.000111	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.71e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTEN—hematologic cancer	1.71e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	1.71e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTEN—hematologic cancer	1.7e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.69e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.69e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	1.67e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	1.67e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	1.67e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	1.66e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.65e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.65e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.63e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EP300—hematologic cancer	1.62e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.61e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.58e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—hematologic cancer	1.58e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.56e-05	9.94e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.54e-05	9.81e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	1.54e-05	9.78e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.53e-05	9.71e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.52e-05	9.69e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.52e-05	9.68e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—hematologic cancer	1.52e-05	9.68e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NRAS—hematologic cancer	1.52e-05	9.66e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.51e-05	9.59e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.5e-05	9.56e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	1.46e-05	9.28e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	1.45e-05	9.25e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.44e-05	9.16e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—hematologic cancer	1.44e-05	9.13e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MYC—hematologic cancer	1.42e-05	9.03e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	1.42e-05	9e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MYC—hematologic cancer	1.42e-05	9e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	1.41e-05	8.98e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.4e-05	8.91e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.4e-05	8.89e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KRAS—hematologic cancer	1.31e-05	8.34e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KRAS—hematologic cancer	1.31e-05	8.31e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.29e-05	8.23e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.21e-05	7.66e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	1.2e-05	7.64e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.19e-05	7.56e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—hematologic cancer	1.17e-05	7.46e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TP53—hematologic cancer	1.17e-05	7.41e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TP53—hematologic cancer	1.16e-05	7.39e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.15e-05	7.32e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HRAS—hematologic cancer	1.11e-05	7.09e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HRAS—hematologic cancer	1.11e-05	7.07e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.1e-05	7e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—hematologic cancer	1.07e-05	6.78e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—hematologic cancer	1.06e-05	6.76e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.05e-05	6.7e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—hematologic cancer	9.84e-06	6.26e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—hematologic cancer	9.81e-06	6.24e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—hematologic cancer	9.72e-06	6.18e-05	CbGpPWpGaD
